Erratum to: Understanding and preventing type 1 diabetes through the unique working model of TrialNet (Diabetologia, 10.1007/s00125-017-4384-2)

Manuela Battaglia, Mark S. Anderson, Jane H. Buckner, Susan M. Geyer, Peter A. Gottlieb, Thomas W.H. Kay, Åke Lernmark, Sarah Muller, Alberto Pugliese, Bart O. Roep, Carla J. Greenbaum, Mark Peakman

Research output: Contribution to journalComment/debate

1 Scopus citations

Abstract

An editorial change altered the meaning of a sentence in this review, implying that TrialNet only started conducting clinical trials in 2016. The sentence should have read: At the time of writing (2016), TrialNet is conducting clinical trials with researchers from 18 clinical centres in the USA, Canada, Finland, UK, Italy, Germany, Sweden, Australia and New Zealand.

Original languageEnglish (US)
Pages (from-to)2540
Number of pages1
JournalDiabetologia
Volume60
Issue number12
DOIs
StatePublished - Dec 1 2017

ASJC Scopus subject areas

  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism

Fingerprint Dive into the research topics of 'Erratum to: Understanding and preventing type 1 diabetes through the unique working model of TrialNet (Diabetologia, 10.1007/s00125-017-4384-2)'. Together they form a unique fingerprint.

Cite this